Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
1.580
-0.090 (-5.39%)
Sep 28, 2026, 11:09 AM EDT - Market open
Skye Bioscience Employees
Skye Bioscience had 2 employees as of June 30, 2026.
Employees
2
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$25,246,289
Market Cap
7.00M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 2 | - | - |
| Mar 31, 2026 | 2 | -14 | -87.50% |
| Dec 31, 2025 | 12 | -4 | -25.00% |
| Dec 31, 2024 | 16 | 5 | 45.45% |
| Dec 31, 2023 | 11 | 0 | - |
| Dec 31, 2022 | 11 | 2 | 22.22% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CollPlant Biotechnologies | 39 |
| Evogene | 38 |
| Bolt Biotherapeutics | 23 |
| Imunon | 20 |
| Ensysce Biosciences | 10 |
| CNS Pharmaceuticals | 8 |
| Enveric Biosciences | 6 |
| XTL Biopharmaceuticals | 5 |
SKYE News
- 17 days ago - Skye Bioscience Proxy statement: Proxy filing - Filings
- 5 weeks ago - Skye Bioscience Proxy statement: Proxy filing - Filings
- 5 weeks ago - Skye Bioscience Inc trading halted, news pending - TheFly
- 5 weeks ago - Skye Bioscience Proxy statement: Proxy filing - Filings
- 5 weeks ago - Skye Bioscience Proxy statement: Proxy filing - Filings
- 6 weeks ago - Skye Bioscience Inc trading halted, news pending - TheFly
- 6 weeks ago - Skye Bioscience to acquire Redx Pharma via scheme of arrangement - TheFly
- 6 weeks ago - Skye Bioscience Inc trading resumes - TheFly